Navigation Links
MiStent SES demuestra ser único en el entorno clínico
Date:10/28/2013

tent SES

El sistema de stent coronario liberador de sirolimus y de polímero absorbente MiStent (MiStent SES®) se ha diseñado para optimizar el cicatrizado en los pacientes con enfermedad arterial coronaria. El recubrimiento de rápida absorción de MiStent tiene como objetivo controlar la liberación del fármaco de forma precisa y consistente y limitar la exposición del polímero para reducir los riesgos de seguridad asociados a las tecnologías de stent liberador de fármaco comercialmente disponible.

El innovador sistema MiStent SES incluye un recubrimiento de stent propio que contiene un fármaco cristalino (sirolimus) y un polímero absorbente. El recubrimiento proporciona liberación controlada y sostenida a niveles terapéuticos del fármaco, al tiempo que el polímero se reblandece y se dispersa desde el stent hasta dentro del tejido adyacente. Estas propiedades está previsto que mejoren la seguridad en comparación con los polímeros permanentes convencionales DES.

Usando un fármaco aprobado (sirolimus) y un polímero (PLGA), la tecnología de fluido supercrítico patentada de Micell permite un control riguroso del recubrimiento fármaco/polímero que se aplicará en un stent metálico. MiStent SES mejora los beneficios del sistema de stent coronario cobalto-cromo Genius® MAGIC de Eurocor (Marca CE), un stent metálico de última generación, que ha demostrado un suministro excelente, conformación y flexibilidad.

Los resultados realizados en estudios de animales han determinado que el recubrimiento se libera del stent en un periodo de entre 45 y 60 días, dejando el stent metálico y al polímero absorbido de forma completa dentro del tejido colindante a los 90 días para promover la permeabilidad a largo plazo y compatibilidad con la arteria.

Micell recibió la ap
'/>"/>

SOURCE Micell Technologies
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6

Related medicine technology :

1. MiStent SES erweist sich im klinischen Umfeld als einzigartig
2. MiStent SES Shown to be Unique in Clinical Setting
3. Micell Technologies Announces Development and Distribution Agreement to Bring MiStent SES to China
4. Micell Technologies Receives CE Mark Approval for MiStent SES
5. Blue Belt Technologies annonce que le Golden Jubilee National Hospital a réalisé la première opération NavioPFS darthroplastie unicondylaire du genou
6. Blue Belt Technologies Announces Golden Jubilee National Hospital Completes Initial NavioPFS Unicondylar Knee Replacement Surgery
7. Blue Belt Technologies kondigt eerste operatie in het Verenigd Koninkrijk aan die wordt uitgevoerd met het NavioPFS-systeem: een unicondylaire knievervanging
8. Blue Belt Technologies Announces First United Kingdom-Based NavioPFS Unicondylar Knee Replacement Surgery
9. Coherus anuncia que CHS-0214 (biosimilar etanercept propuesto) supera punto final primario en decisivo estudio clínico farmacocinético
10. Adamas Pharmaceuticals presenta datos clínicos positivos para ADS-5102, un tratamiento para la disquinesia inducida por levodopa, en el Congreso Mundial del Parkinson
11. Se prepara para entrar en ensayos clínicos una nueva inmunoterapia contra el cáncer
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/21/2014)... Aug. 21, 2014  Zacks.com announces the list of stocks ... Research analysts discuss the latest news and events impacting stocks ... include the Hewlett-Packard (NYSE: HPQ - Free Report ), IBM ... (NYSE: SB - Free Report ), GlaxoSmithKline plc (NYSE: ... (NYSE: FI - Free Report ). Today, ...
(Date:8/21/2014)... 21, 2014 BreedIT Corp., ... the exclusive worldwide license holder and distributor of ... and researchers, today is pleased to announce the ... Seach Ltd, a leading Israeli medical Cannabis breeder. ... develop new breeds of medical Cannabis to meet ...
(Date:8/21/2014)... , Aug. 21, 2014  ACI Clinical ... for independent Data Monitoring Committees. Using ... 30 percent over industry standard costs and receive ... industry leader in committee services. Leveraging ... recruitment and contracting, charter development, statistical programming and ...
Breaking Medicine Technology:The Zacks Analyst Blog Highlights: Hewlett-Packard, IBM, Safe Bulkers, GlaxoSmithKline and Frank's International 2The Zacks Analyst Blog Highlights: Hewlett-Packard, IBM, Safe Bulkers, GlaxoSmithKline and Frank's International 3The Zacks Analyst Blog Highlights: Hewlett-Packard, IBM, Safe Bulkers, GlaxoSmithKline and Frank's International 4The Zacks Analyst Blog Highlights: Hewlett-Packard, IBM, Safe Bulkers, GlaxoSmithKline and Frank's International 5The Zacks Analyst Blog Highlights: Hewlett-Packard, IBM, Safe Bulkers, GlaxoSmithKline and Frank's International 6The Zacks Analyst Blog Highlights: Hewlett-Packard, IBM, Safe Bulkers, GlaxoSmithKline and Frank's International 7The Zacks Analyst Blog Highlights: Hewlett-Packard, IBM, Safe Bulkers, GlaxoSmithKline and Frank's International 8The Zacks Analyst Blog Highlights: Hewlett-Packard, IBM, Safe Bulkers, GlaxoSmithKline and Frank's International 9The Zacks Analyst Blog Highlights: Hewlett-Packard, IBM, Safe Bulkers, GlaxoSmithKline and Frank's International 10The Zacks Analyst Blog Highlights: Hewlett-Packard, IBM, Safe Bulkers, GlaxoSmithKline and Frank's International 11BreedIT Ltd. and Seach Ltd. Form KanaboSeed to Develop New Medical Cannabis Varieties 2BreedIT Ltd. and Seach Ltd. Form KanaboSeed to Develop New Medical Cannabis Varieties 3BreedIT Ltd. and Seach Ltd. Form KanaboSeed to Develop New Medical Cannabis Varieties 4ACI Clinical: Innovation and Savings in Data Safety Monitoring Committees 2
(Date:8/21/2014)... of Montreal, the regions of the brain below the ... bodies, movements and, critically, they interact more effectively after ... helped us the learn sequences of movements (motor learning), ... important in information consolidation, especially information linked to a ... a period of sleep, the brain network of these ...
(Date:8/21/2014)... Artisan Business Group Inc., will lead the 3rd ... China October 12-19, 2014. The 2014 EB-5 Delegation provides ... of Shenzhen and Guangzhou. This trip is specifically organized ... meet with major Chinese migration agents and businesses to ... , The trade mission activities include: meetings with ...
(Date:8/21/2014)... Quantum Innovations, Inc . and ... announce the healthcare technology platform, PWeR® 2.0 , ... The company anticipates provisioning its first provider over the ... physicians, via interfaces, to medical laboratory, pharmacy, secure fax ... data exchanges and medical clearing houses. , Noel ...
(Date:8/21/2014)... Being overweight or obese may be one ... is no cure, patients have learned how to ... such as losing excess weight and following a medically ... joint disorder which causes discomfort and pain in the ... significantly reduce one’s quality of life. Although it is ...
(Date:8/21/2014)... 2014 Poorly-made dental restorations – whether ... a range of health consequences for patients. To ensure ... important that dentists and patients have a full understanding ... what materials are used in the process. , Some ... office. Others do not even think twice about where ...
Breaking Medicine News(10 mins):Health News:Learning to play the piano? Sleep on it! 2Health News:Artisan Business Group announces 2014 EB-5 Investment Trade Mission to China 2Health News:Grace Century’s Electronic Health Records Project, Quantum Innovations, Announces That PWeR® Healthcare Technology Platform is Ready for Deployment 2Health News:Grace Century’s Electronic Health Records Project, Quantum Innovations, Announces That PWeR® Healthcare Technology Platform is Ready for Deployment 3Health News:Grace Century’s Electronic Health Records Project, Quantum Innovations, Announces That PWeR® Healthcare Technology Platform is Ready for Deployment 4Health News:Diet Doc’s Medical Weight Loss Programs Announces Safe and Fast Weight Loss That Teach Patients How to Relieve Osteoarthritis Pain 2Health News:Diet Doc’s Medical Weight Loss Programs Announces Safe and Fast Weight Loss That Teach Patients How to Relieve Osteoarthritis Pain 3Health News:4 Questions to Ask Before Your Next Dentist Appointment 2Health News:4 Questions to Ask Before Your Next Dentist Appointment 3
... Starpharma Holdings Limited announced the commencement in the U.S. ... of SPL7013 Gel (VivaGel(TM)) in sexually active young ... the study, funded by the U.S. National Institutes of ... the first time in sexually active young women to ...
... in the United States -- more than double the percentage ... at least 21 serious disorders, according to the latest ... has failed to make progress on expanding the newborn screening ... of Columbia require screening for the 29 core, treatable, conditions. ...
... smart enough to cash in on the Dutch laws. ... on a marijuana cookie while touring in the Netherlands. ... it is not legal here. I don't ever do anything ... ,The 25-year-old singer said that the cookie was ...
... be participating in the Memory Ride for Alzheimer's Research on ... the disease that affects more than 5 million Americans. ... Memory Ride has a personal story to tell -- about ... struggled with the disease. ,The Alzheimer's Association is ...
... spotted returning home without her shoes at 5 in the morning ... jailbird had been to a party at the Sunset Tower Hotel ... the hotel heiress rep said that Hilton was exhausted after visiting ... ,The Simple Life star returned to the LA club scene ...
... million worldwide. In a new study, UCLA researchers measured the ... beyond just the physical symptoms of the disease and ... well-being, which may help clinicians guide treatment. The study appears ... ,Our results revealed that to effectively treat hepatitis B patients, ...
Cached Medicine News:Health News:Trial of VivaGel in Sexually Active Young Women Commences 2Health News:All Babies in Massachusetts Should Be Screened for Life-Threatening Disorders 2Health News:Researchers Develop Tool to Gauge Quality of Life of Hepatitis B Patients 2
... ,MARS Technology is the next generation in ... addition to our current family of "digital ... of new technological breakthroughs in signal processing. ... signal resulting in superior performance during challenging ...
The new Nellcor N-45 Handheld Pulse Oximeter is compatible with our complete line of OxiMax Pulse Oximetry Sensors, so clinicians have the convenience of Nellcors most advanced sensor technology in a...
... handheld oximeter has been converted to the ... now compatible with the entire line of ... Sensor and SoftCare Nonadhesive Sensors. The redesigned ... Nellcor's latest advanced signal processing technology, which ...
... The Nellcor N395 Pulse Oximeter with ... challenging motion conditions, cutting through nonspecific noise ... SpO 2 and pulse rate values. ... equipped with SatSeconds Alarm Management, a breakthrough ...
Medicine Products: